An anti-VEGF strategy was recently shown to trigger tumour relapse and metastasis, and a plausible relapse mechanism suggests that the effect of anti-VEGF may lead to immunosuppression (Tamura et al., 2019; Zhang et al., 2019; Song et al., 2020). Here, VEGFA is linked to neoplasm.